X-149496444-G-C

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_000202.8(IDS):​c.781C>G​(p.Pro261Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,207,511 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 51 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00061 ( 0 hom., 21 hem., cov: 23)
Exomes 𝑓: 0.000089 ( 0 hom. 30 hem. )

Consequence

IDS
NM_000202.8 missense

Scores

3
2
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.0170
Variant links:
Genes affected
IDS (HGNC:5389): (iduronate 2-sulfatase) This gene encodes a member of the sulfatase family of proteins. The encoded preproprotein is proteolytically processed to generate two polypeptide chains. This enzyme is involved in the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this gene are associated with the X-linked lysosomal storage disease mucopolysaccharidosis type II, also known as Hunter syndrome. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.068737805).
BP6
Variant X-149496444-G-C is Benign according to our data. Variant chrX-149496444-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 589455.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=1, Uncertain_significance=1}. Variant chrX-149496444-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000606 (68/112186) while in subpopulation AFR AF= 0.00188 (58/30847). AF 95% confidence interval is 0.00149. There are 0 homozygotes in gnomad4. There are 21 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 21 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IDSNM_000202.8 linkc.781C>G p.Pro261Ala missense_variant Exon 6 of 9 ENST00000340855.11 NP_000193.1 P22304-1
IDSNM_001166550.4 linkc.511C>G p.Pro171Ala missense_variant Exon 6 of 9 NP_001160022.1 P22304B4DGD7
IDSNM_006123.5 linkc.781C>G p.Pro261Ala missense_variant Exon 6 of 8 NP_006114.1 P22304-2
IDSNR_104128.2 linkn.950C>G non_coding_transcript_exon_variant Exon 6 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IDSENST00000340855.11 linkc.781C>G p.Pro261Ala missense_variant Exon 6 of 9 1 NM_000202.8 ENSP00000339801.6 P22304-1
ENSG00000241489ENST00000651111.1 linkc.148C>G p.Pro50Ala missense_variant Exon 11 of 14 ENSP00000498395.1 B3KWA1

Frequencies

GnomAD3 genomes
AF:
0.000589
AC:
66
AN:
112132
Hom.:
0
Cov.:
23
AF XY:
0.000554
AC XY:
19
AN XY:
34284
show subpopulations
Gnomad AFR
AF:
0.00182
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000940
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000268
AC:
49
AN:
183076
Hom.:
0
AF XY:
0.000192
AC XY:
13
AN XY:
67618
show subpopulations
Gnomad AFR exome
AF:
0.00213
Gnomad AMR exome
AF:
0.000255
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00101
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000895
AC:
98
AN:
1095325
Hom.:
0
Cov.:
30
AF XY:
0.0000831
AC XY:
30
AN XY:
360805
show subpopulations
Gnomad4 AFR exome
AF:
0.00182
Gnomad4 AMR exome
AF:
0.000142
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000828
Gnomad4 SAS exome
AF:
0.0000555
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000119
Gnomad4 OTH exome
AF:
0.000348
GnomAD4 genome
AF:
0.000606
AC:
68
AN:
112186
Hom.:
0
Cov.:
23
AF XY:
0.000611
AC XY:
21
AN XY:
34348
show subpopulations
Gnomad4 AFR
AF:
0.00188
Gnomad4 AMR
AF:
0.000939
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000627
ESP6500AA
AF:
0.00104
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000231
AC:
28

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Mucopolysaccharidosis, MPS-II Uncertain:1Benign:1
Dec 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 07, 2024
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: literature only

Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Missense variant in a gene with a low rate of benign missense variation (PP2_Supporting), Patient’s phenotype or family history highly specific for the disease (PP4_Moderate) -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Nov 09, 2016
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Mucopolysaccharidosis, MPS-III-A Benign:1
Feb 05, 2021
Natera, Inc.
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.087
T
BayesDel_noAF
Uncertain
0.10
CADD
Benign
8.9
DANN
Benign
0.71
DEOGEN2
Pathogenic
0.82
D;.;.
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.82
T;T;T
M_CAP
Pathogenic
0.75
D
MetaRNN
Benign
0.069
T;T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
0.72
N;N;.
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.8
N;N;.
REVEL
Uncertain
0.60
Sift
Benign
0.51
T;T;.
Sift4G
Benign
0.63
T;T;T
Polyphen
0.0010
B;B;.
Vest4
0.47
MVP
0.99
MPC
0.20
ClinPred
0.0032
T
GERP RS
2.8
Varity_R
0.12
gMVP
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141720810; hg19: chrX-148577975; API